Pepti Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.9/10
Best for: a low all-in starter price on compounded GLP-1s, with every dose price published up front
Price is where Pepti scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Included
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Pepti is a Delaware-registered telehealth platform selling doctor-prescribed compounded peptides and GLP-1s, with a published shipping list of 49 states plus DC. Injectable semaglutide starts at $99 and tirzepatide at $159 per 28-day supply, rising with dose to $199 and $319. Each price covers medication, physician review, labs, refill management and shipping, with no membership fee. Pepti is a platform, not a prescriber, and does not bill insurance.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Pepti
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Pepti at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $99/4 wks (billed per 4 weeks)
- Pricing model
- Scales with dose: higher doses cost more
- What's included
- Medication · Consult · Shipping · Labs
- Availability
- 49 states + DC
- FDA status
- No FDA warning letter on record
How we scored Pepti
Each dimension is scored algorithmically from Pepti’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
8.9/10At $99/mo (per 4 weeks), Pepti runs about 46% below the $182 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
7.9/10Pepti offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.2/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.9/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.5/10Pepti is available in 49 states plus DC: all but Oklahoma. FSA/HSA cards are accepted.
Support10%
5.7/10Pepti provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Pepti review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 49 states plus DC
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $99–$159/mo across 2 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Pepti
We walked Pepti’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Browse the public catalog, where the price of every dose is listed before any account is created
- 2Open the free assessment for a drug and pick a starter dose or the dose you already take
- 3A chat-style intake opens, restating the all-in price and that it renews when your supply runs out
- 4Stopped at the first typed-answer field of the chat intake, before any personal or medical details
- Prices for all six semaglutide and six tirzepatide doses are shown on the homepage, product pages and assessment screen.
- The refund policy says payment is collected at checkout before provider review and is fully refunded if you are not approved.
- Billing terms say medication bills every 28 days, so the charge date moves through the calendar.
- The site claims 50 states, but the published shipping list has 49 states plus DC, with Oklahoma missing.
- Product pages show third-party lab results by lot, including sterility, endotoxin and potency.
Pepti customer support
- Hours
- 24/7
GLP-1 medications Pepti offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Pepti offers
Beyond GLP-1s, Pepti also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
$99 per 28-day supply at 0.25mg; 0.5mg $109, 1mg $129, 1.7mg $179, 2mg $189, 2.5mg $199. All-in: medication, physician care, labs and shipping.
$159 per 28-day supply at 2.5mg; 5mg $179, 7.5mg $189, 10mg $239, 12.5mg $249, 15mg $319. All-in: medication, physician care, labs and shipping.
Ready to get started?
Plans and promotions change often, so check Pepti's current pricing and active discounts before you decide.
What we like
- Injectable semaglutide starts at $99 and tirzepatide at $159 all-in, with no membership fee on top.
- Publishes the exact price for every dose of both drugs, so you can see what titrating up will cost before you start.
- Publishes a shipping list of 49 states plus DC, and a provider denial means a full refund.
- Names the reviewing physician, Dr. Gene Lee MD, and posts third-party sterility and potency results by lot.
Watch-outs
- Billed every 28 days rather than monthly, so you pay 13 times a year, not 12.
- Price rises with dose: semaglutide tops out at $199 and tirzepatide at $319 per supply.
- The site says it serves 50 states, but its own list leaves out Oklahoma and counts DC instead.
- No compounding pharmacy is named in advance; you only learn it from your medication label.
- The listed address, a Newark Delaware suite, is a shared registered-agent address rather than a clinical office.
- Cash-pay only with no insurance billing, and medication can't be refunded once it ships.
Is Pepti worth it?
The short version of what Pepti offers is a low all-in starter price on compounded GLP-1s, with every dose price published up front. It runs $99/month (per 4 weeks); there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. No single feature of its GLP-1 program sets it apart from the category on its own, so the price and terms below are the things to compare.
Beyond the medication itself, Pepti includes lab testing. It also takes HSA/FSA payment and lets you cancel anytime.
How much Pepti costs
Compounded semaglutide runs $99/month (per 4 weeks) and compounded tirzepatide runs $159/month (per 4 weeks).
Because Pepti's headline figure is listed as “per 4 weeks”, we don't set it against the roughly $182 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Pepti with the month-to-month prices of the alternatives below instead.
Eden (about $99/month) is one of the closest alternatives to weigh Pepti against.
Medications: what Pepti prescribes
Pepti prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.
Who Pepti is best for, and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program and are comfortable comparing it against the alternatives below.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Pepti is available in 49 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Pepti is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
Price is where Pepti scores best in our breakdown.
Ready to start with Pepti?
From $99/4 wks (billed per 4 weeks). See current pricing and start your free consultation.
Pepti might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Pepti vs…
Pepti scores7.9/10
Side-by-side pricing, medications and scores. Pick a matchup.
Pepti vs Amazon One Medical
Amazon One Medical scores 8.5/10
Pepti vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Pepti review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Pepti's current pricing
Plans from $99/4 wks (billed per 4 weeks). Start your free consultation to check eligibility and today's price.